Announcement
Thank you for attending THSNA 2026. The virtual meeting is now closed.
Thank you for attending THSNA 2026. The virtual meeting is now closed.
Posters/Exhibits/Break > Session
Posters/Exhibits/Break
Presentations
A1. ANTICOAGULATION CLINICS | |||||
|
(200) IMPORTANCE OF ANTICOAGULATION CLINICS IN IDENTIFICATION OF ANTIPHOSPHOLIPID ANTIBODY SYNDROME MISCLASSIFICATION Deborah Gillard1, Lisa Baumann Kreuziger1,2,3, Jennifer Hardman1. 1Froedtert Health, Milwaukee, WI, USA 2Medical College of Wisconsin, Milwaukee, WI, USA 3Versiti Blood Research Institute, Milwaukee, WI, USA |
||||
A4. DISORDERS OF PLATELET NUMBER OR FUNCTION | |||||
|
(201) A RETROSPECTIVE US CLAIMS DATABASE STUDY ASSESSING TREATMENT PATTERNS AND BLEEDING EPISODES IN PATIENTS WITH PREVIOUSLY TREATED PRIMARY IMMUNE THROMBOCYTOPENIA Joao Da Silva1, Yu-Chen Yeh2, Firas Dabbous3, Carlos E Bertaglia Goncalves4, Sarah Hale4, Qian Li3, Mei Lu4, Sean Sana2, Dorothy Romanus2. 1Thermo Fisher Scientific, Azores, Portugal 2Takeda Development Center Americas, Inc., Cambridge, MA, USA 3Thermo Fisher Scientific, Bethesda, MD, USA 4Takeda Pharmaceuticals U.S.A., Inc, Lexington, MA, USA |
||||
|
(202) HEPARIN INDUCED THROMBOCYTOPENIA IN ORTHOPEDIC SURGERY PATIENTS - A NATIONAL INPATIENTS SAMPLE DATABASE STUDY Sruthi/P Ramanan1, Kalaivani Babu2, Srinishant Rajarajan2, Yin Yue3, Deep Shah1. 1AHN Cancer Institute, Allegheny Health Network, Pittsburgh, PA, USA 2Department of Internal Medicine, Allegheny Health Network, Pittsburgh, PA, USA 3Allegheny Health Network, Pittsburgh, PA, USA |
||||
A5. BLOOD COAGULATION AND FIBRINOLYTIC FACTORS | |||||
|
(203) TYPE 2N VON WILLEBRAND DISEASE IN PREGNANCY AND POSTPARTUM: A CASE REPORT Lauren N Durand, Robert Bona. Yale University Dept of Medicine and Pediatrics, New Haven, CT, USA |
||||
A6. DISORDERS OF COAGULATION OR FIBRINOLYSIS | |||||
|
(205) ASSAY PERFORMANCE AND HEAT-INACTIVATION CHALLENGES OF EFANESOCTOCOG ALFA IN FACTOR VIII ACTIVITY AND INHIBITOR TESTING Erin L Aakre, Melissa S Stuart, Julie I Tange, Juliana Perez Botero, Rajiv K Pruthi. Division of Hematopathology, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN, USA |
||||
|
(206) MAJOR ORTHOPEDIC SURGERIES CONDUCTED UNDER FITUSIRAN PROPHYLAXIS IN PEOPLE WITH HEMOPHILIA A AND B, WITH AND WITHOUT INHIBITORS Larissa Bornikova1, Laurent Frenzel2, Kaan Kavakli3, László Nemes4, Stephanie P'ng5, Jing Sun6, Chur-Woo You7, Ezio Zanon8, Vanessa Salinas9, Laurel A. Menapace10, Salim Kichou11, Abhimanyu Yarramaneni10, Yuqian Shen10, Alok Srivastava12. 1Cancer Center, Massachusetts General Hospital, Boston, MA, USA 2Groupe Hospitalier Necker Enfants Malades, Paris, France 3Ege University Faculty of Medicine, Izmir, Turkey 4Central Hospital of Northern Pest – Military Hospital, Budapest, Hungary 5Fiona Stanley Hospital, Murdoch, Australia 6Nanfang Hospital, Guangzhou, China 7Eulji University Hospital, Daejeon, South Korea 8Azienda Ospedale Università di Padova, Padua, Italy 9Center for Inherited Blood, Disorders, Orange, CA, USA 10Sanofi, Cambridge, MA, USA 11Sanofi Genzyme, Paris, France 12St. John's Medical College Hospital, Bengaluru, India |
||||
|
(207) LIMITATION OF AUTOMATED VON WILLEBRAND TESTING IN IDENTIFYING A CASE OF ACQUIRED VON WILLEBRAND SYNDROME Shannon Goodall, Maissaa Janbain. Section of Hematology and Medical Oncology, Tulane School of Medicine, New Orleans, LA, USA |
||||
|
(209) INCREASED LEVELS OF D-DIMER AND PLASMINOGEN ACTIVATOR INHIBITOR-1 IN IMMUNE THROMBOCYTOPENIA: IMPLICATIONS FOR THROMBOTIC COMPLICATIONS Kannan Meganathan1, Jeevanatham. Kaviarasi1, Chitrali L Roy1, Ravi Ranjan2, Manoranjan Mahapatra2, Renu Saxena2, Jawed Fareed3. 1Blood and Vascular Biology Research Lab, Department of Biotechnology, Central University of Tamil Nadu, Thiruvarur 610101. INDIA, Thiruvarur, India 2Department of Hematology, All India Institute of Medical Sciences, New Delhi 110029. INDIA, New Delhi, India 3Department of Molecular Pharmacology and Neuroscience, Loyola University Chicago IL 60153, USA, Chicago, IL, USA |
||||
|
(211) INVESTIGATING THE EFFECT OF POPULATION PHARMACOKINETIC-GUIDED PDVWF/FVIII (1:1) PROPHYLAXIS FOR SEVERE VWD IN A REAL-WORLD SETTING: THE POPPK-WILPROPHY STUDY Robert F. Sidonio, Jr.1, Ron A. A. Mathôt2. 1Professor of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA 2Department of Hospital Pharmacy & Clinical Pharmacology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands |
||||
|
(212) EVALUATING THE SAFETY AND TOLERABILITY OF SWITCHING FROM EMICIZUMAB TO FITUSIRAN PROPHYLAXIS IN MALES AGED ≥12 YEARS WITH SEVERE HEMOPHILIA A, WITH AND WITHOUT INHIBITORS: SWITCH STUDY Guy Young1, Ekta S Chhabra2, Shariq Ali2, Lila-Sabrina Fetita3, Marek Demissie2, Abhimanyu Yarramaneni2, Chanchala Kaddi2, Sheng C Chou4. 1Children’s Hospital Los Angeles, Los Angeles, CA, USA 2Sanofi, Cambridge, MA, USA 3Sanofi Genzyme, Paris, France 4Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan |
||||
A7. PATHOPHYSIOLOGY OF THROMBOSIS | |||||
|
(213) EVALUATION OF BOVINE MUCOSAL HEPARINS USING PLASMA-BASED AND WHOLE BLOOD CLOTTING ASSAYS Troy LaBore, Brent Cudal, Monica Pastorious, Debra Hoppensteadt, Jawed Fareed, Walter Jeske, Jeanine Walenga. Loyola University Chicago Department of Pathology and Laboratory Medicine, Chicago, IL, USA |
||||
A8. ANTITHROMBOTIC THERAPY | |||||
|
(215) RETHINKING EXTENDED ANTICOAGULATION IN CANCER: IS LESS MORE? A SYSTEMATIC REVIEW AND META-ANALYSIS OF CLINICAL TRIALS Ursula Medeiros Araujo de Matos1, Eduardo Dan Itaya1, Moana Divina da Silva Santiago1, Patrick Froelich Meldola2, Pedro L Lage Bodour Danielian3, Gustavo J Silva Sanchez1, Swarup Kumar4, Ritika Vankina4. 1Internal Medicine Department, University of Connecticut, Farmington, CT, USA 2Federal University of Santa Catarina, School of Medicine, Santa Catarina, Brazil 3Harvard T. H. Chan School of Public Health, Boston, MA, USA 4Hematology and Oncology Department, University of Connecticut, Farmington, CT, USA |
||||
|
(216) RISK FACTORS FOR SUPRATHERAPEUTIC APTTS ON HEPARIN INTRAVENOUS INFUSION Wade Tung, Katelyn Sylvester, Kaitlin Crowley, Dareen Kanaan. Brigham and Women's Hospital, Boston, MA, USA |
||||
A9. INFORMATIONAL ABSTRACT (POSTER ONLY) | |||||
|
(217) EVALUATION OF UPDATED PROTOCOL FOR INTRAOPERATIVE ANTITHROMBIN-III AND UNFRACTIONATED HEPARIN ADMINISTRATION DURING CARDIAC SURGERY Razan Fannoun, Stephanie Davis, Katie Dane, John Lindsley, Margaret Buck, Jessica Crow, Promise Ariyo. The Johns Hopkins Hospital, Baltimore, MD, USA |
||||
|
(218) EVALUATION OF ANTITHROMBIN III UTILIZATION IN CARDIOVASCULAR SURGERY REQUIRING CARDIOPULMONARY BYPASS—A RETROSPECTIVE REVIEW OF INSTITUTIONAL PRACTICE Ekaterina Pechenko1, Jen Osborn1, Josh Breeding2, Vrushali Pachpande1. 1M Health Fairview University of Minnesota Medical Center, Minneapolis, MN, USA 2M Health Fairview Southdale Hospital, Edina, MN, USA |
||||
|
(219) IMPLEMENTATION AND OUTCOMES OF A PHARMACIST-DRIVEN PROTOCOL FOR DIRECT THROMBIN INHIBITOR TITRATION IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA Amber L Woolley, Anne E Rose. UW Health, Madison, WI, USA |
||||